CHOP Researchers Redefine the Mechanisms of Dravet Syndrome
Published on
Recovery of normal signaling of a key brain cell may be a critical therapeutic target to reduce seizures and cognitive impairment.
Published on
Recovery of normal signaling of a key brain cell may be a critical therapeutic target to reduce seizures and cognitive impairment.
Published on
A transformative gift from local philanthropists Steve and Susan Kelly launches first-of-its-kind hub for pediatric cancer immunotherapy.
Published on
Breaking Through with Madeline Bell’s “Women Leading the Way” series highlights stories about some of CHOP’s amazing women scientists, and the remarkable breakthroughs they’re making.
Published on
Dr. Karen Puopolo is recognized for her outstanding contributions in the field of perinatal medicine.
Published on
The new center, funded by the National Institute of Environmental Health Sciences, aims to identify and protect children in vulnerable communities from environmental exposures.
Published on
More than 250 experts gathered in Philadelphia and virtually to discuss the latest scientific advancements and breakthroughs in pediatric precision medicine oncology.
Published on
Learning to adjust talkativeness could be an important growth opportunity for verbally fluent people with autism.
Published on
CHOP is proud to announce Marcia Wallace as its first Supplier Diversity Program Manager. In this role, which she assumed in fall 2021, she leads CHOP’s Supply Chain team and works closely with CHOP’s Healthier Together Initiative.
Published on
CHOP researchers have shown that linking a tumor-killing prodrug to a macromolecular carrier of the Poloxamer family improves retention of the drug in treatment-resistant neuroblastoma tumors.
Published on
In a COG trial, CHOP researchers found adding bortezomib to chemotherapy significantly improved overall survival in children and young adults with newly diagnosed T-cell lymphoblastic lymphoma (T-LL).